{"id":"desloratadine-placebo-tablet","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo is an inert formulation used as a control in clinical trials to assess the efficacy of an active drug by comparison. It produces no pharmacological action and serves only as a reference standard to distinguish true drug effects from placebo response.","oneSentence":"This is a placebo tablet containing no active pharmaceutical ingredient and therefore has no mechanistic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:32:24.962Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT00783211","phase":"PHASE4","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-08-01","conditions":"Seasonal Allergic Rhinitis","enrollment":722},{"nctId":"NCT00867191","phase":"PHASE4","title":"Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-02-01","conditions":"Seasonal Allergic Rhinitis","enrollment":233},{"nctId":"NCT00783354","phase":"PHASE4","title":"A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-01","conditions":"Urticaria, Chronic Idiopathic Urticaria","enrollment":129},{"nctId":"NCT00751218","phase":"PHASE4","title":"A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-05-06","conditions":"Urticaria","enrollment":174},{"nctId":"NCT00751166","phase":"PHASE4","title":"A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Urticaria","enrollment":149},{"nctId":"NCT00783146","phase":"PHASE4","title":"Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-08-01","conditions":"Seasonal Allergic Rhinitis","enrollment":728},{"nctId":"NCT01918033","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-20","conditions":"Perennial Allergic Rhinitis","enrollment":608},{"nctId":"NCT01916967","phase":"PHASE3","title":"An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-08-27","conditions":"Urticaria","enrollment":239},{"nctId":"NCT00405964","phase":"PHASE3","title":"Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Allergic Rhinitis","enrollment":716},{"nctId":"NCT00406783","phase":"PHASE3","title":"Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-08","conditions":"Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial","enrollment":547},{"nctId":"NCT02320396","phase":"PHASE3","title":"Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2015-01-09","conditions":"Seasonal Allergic Rhinitis","enrollment":449},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT02904304","phase":"PHASE3","title":"Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu","status":"SUSPENDED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2020-12","conditions":"Cold","enrollment":150},{"nctId":"NCT01400828","phase":"PHASE3","title":"Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2011-06","conditions":"Seasonal Allergic Rhinitis","enrollment":239},{"nctId":"NCT01720485","phase":"PHASE3","title":"Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment","status":"UNKNOWN","sponsor":"EMS","startDate":"2013-10","conditions":"Allergic Rhinitis","enrollment":234},{"nctId":"NCT01740284","phase":"PHASE3","title":"A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2008-09","conditions":"Allergic Rhinoconjunctivitis","enrollment":46},{"nctId":"NCT01108783","phase":"PHASE3","title":"A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2003-04","conditions":"Seasonal Allergic Rhinitis","enrollment":720},{"nctId":"NCT00633919","phase":"PHASE2, PHASE3","title":"Efficacy of SLITone in House Dust Mite Allergic Patients","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2006-07","conditions":"Allergy","enrollment":124}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Aerius, Clarinex, SCH 34117, descarboethoxyloratadine","Aerus"],"phase":"marketed","status":"active","brandName":"Desloratadine placebo tablet","genericName":"Desloratadine placebo tablet","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo tablet containing no active pharmaceutical ingredient and therefore has no mechanistic effect. Used for Clinical trial control (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}